Bringing the fundamentals into focus…
Back to Prelude Therapeutics Incorporated
How Prelude Therapeutics Incorporated stacks up
PRLD · against 317 other Healthcare companies of similar size
Growth
90/ 100
Near the top of its peers.
Ranked #29 of 318 · scores higher than 91% of peers
Bars: peers in each 10-point band of the growth score31 peers with a growth score of 90–100, including PRLD · Click a bar to see the companies
Why growth scores 90?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its revenue growth, which is stronger than most Healthcare peers.
- 3-year revenue growth is not reported, so it is left out of the score.
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over the last year: stronger than 93% of peers. Revenue growth: 73.4% vs peer median 6.1%
Metric by metric
Position: dot = PRLD, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | PRLD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 330 reported | 73.4% | 3.0% | 92% | 33% | |
| Earnings per share growthHigher is better · 145 reported | Not reported | 2.2% | — | — | 33% |
| 3-year revenue growthHigher is better · 309 reported | Not reported | 3.7% | — | — | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around PRLD| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 2 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 2 | 592M ILS (≈$160M) | 99 | 84 | |
| 2 | 433M USD | 99 | 81 | |
| 27 | 468M USD | 91 | 40 | |
| 27 | 296M USD | 91 | 66 | |
| 29 | 6.2B TWD (≈$193M) | 90 | 42 | |
| 29 | 4.6B SEK (≈$462M) | 90 | 37 | |
| 29 | 302M USD | 90 | 42 | |
| 32 | 3.1B CNY (≈$438M) | 89 | 46 | |
| 33 | 23.7B INR (≈$284M) | 88 | 58 | |
| 33 | 421M USD | 88 | 52 | |
| 35 | 3.0B HKD (≈$388M) | 87 | 64 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score